Assistant Professor in Translational Neuropharmacologist in Metabolic Engineering
Listed on 2026-02-23
-
Healthcare
Medical Science, Neurology
Overview
Assistant Professor
Translational Neuropharmacologist in Metabolic Engineering
UNIVERSITY OF GEORGIA
Position Summary
The University of Georgia invites applications for a 9-month, tenure-track faculty position in the interdisciplinary area of Translational Neuropharmacologist in Metabolic Engineering, as part of the 2025–2026 Presidential Strategic Faculty Hiring Initiative (PHI). This position represents a collaborative recruitment effort between the Department of Physiology and Pharmacology in the College of Veterinary Medicine and the School of Chemical, Materials, and Biomedical Engineering (CMBE) in the College of Engineering and the Isakson Center for Neurological Disease Research (ICNDR).
We seek candidates whose work bridges neuropharmacology, metabolic engineering, synthetic biology, gut-brain physiology, and translational neuroscience to advance therapeutic strategies for neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, and related disorders. Areas of interest include (but are not limited to):
- Translational neuropharmacology and biotherapeutic discovery including computational and experimental approaches to identify and engineer genetic elements encoding, for example, metabolic pathways and enzymes leading to development of new cell- and microbial-biotherapeutic agents for preclinical evaluation in cell-based and animal models of neurodegenerative diseases, including Parkinson’s and Alzheimer’s diseases, among other related neurological disorders.
- Neurobiological mechanisms of gut microbiome-brain axis in pathogenesis of neuroinflammatory and neurodegenerative conditions, and identification of novel biotherapeutic targets for neuroprotection, neurorestoration, and neuromodulation.
- Precision medicine approaches integrating metabolomic, genomic and phenomics datasets to understand and predict pharmacokinetics, pharmacodynamics and toxicity of cell-based biotherapeutics
- Designing, manufacturing and scaling bioengineered biotherapeutics to optimize stability, delivery, efficacy and safety across various model systems, as required for IND enabling studies.
The successful candidate will be expected to accelerate the development of metabolite-producing cell systems and advance preclinical and clinical testing for neurodegenerative diseases (e.g. Parkinson’s and Alzheimer’s), and specifically:
MINIMUM QUALIFICATIONS
- A Ph.D. in biomedical sciences including pharmacology, physiology, neuroscience, pathology and other related fields.
- Translational research experience related to neurodegenerative diseases.
- Evidence of research productivity in translational research.
PREFERRED QUALIFICATIONS
- Demonstrated excellence—or strong potential—in areas relevant to biotherapeutic preclinical evaluation of bioengineered neural therapeutics.
- Knowledge in advancing biotherapeutics from preclinical to clinical commercialization.
- A record of interdisciplinary collaboration.
- Commitment to teaching excellence and student mentoring.
- Display a strong integration of engineering methods with biological or biomedical applications.
- Competitive applicants will have a strong record of innovative research bridging neuropharmacology, neuroscience and metabolic engineering with relevance to translational applications.
ADDITIONAL REQUIREMENTS
Candidates must also have a documented research background appropriate for the appointment rank, as evidenced by peer-reviewed publications, extramural…
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).